These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 20656495)
1. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles. Samadi A; Marco-Contelles J; Soriano E; Alvarez-Pérez M; Chioua M; Romero A; González-Lafuente L; Gandía L; Roda JM; López MG; Villarroya M; García AG; Ríos Cde L Bioorg Med Chem; 2010 Aug; 18(16):5861-72. PubMed ID: 20656495 [TBL] [Abstract][Full Text] [Related]
2. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles. Samadi A; Valderas C; de los Ríos C; Bastida A; Chioua M; González-Lafuente L; Colmena I; Gandía L; Romero A; Del Barrio L; Martín-de-Saavedra MD; López MG; Villarroya M; Marco-Contelles J Bioorg Med Chem; 2011 Jan; 19(1):122-33. PubMed ID: 21163662 [TBL] [Abstract][Full Text] [Related]
3. Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling. Samadi A; Estrada M; Pérez C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Marco-Contelles J Eur J Med Chem; 2012 Nov; 57():296-301. PubMed ID: 23078965 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease. Maalej E; Chabchoub F; Oset-Gasque MJ; Esquivias-Pérez M; González MP; Monjas L; Pérez C; de los Ríos C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Romero A; Marco-Contelles J; Samadi A Eur J Med Chem; 2012 Aug; 54():750-63. PubMed ID: 22795665 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives. de Los Ríos C; Egea J; Marco-Contelles J; León R; Samadi A; Iriepa I; Moraleda I; Gálvez E; García AG; López MG; Villarroya M; Romero A J Med Chem; 2010 Jul; 53(14):5129-43. PubMed ID: 20575555 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease. Samadi A; Chioua M; Bolea I; de Los Ríos C; Iriepa I; Moraleda I; Bastida A; Esteban G; Unzeta M; Gálvez E; Marco-Contelles J Eur J Med Chem; 2011 Sep; 46(9):4665-8. PubMed ID: 21669479 [TBL] [Abstract][Full Text] [Related]
7. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231 [TBL] [Abstract][Full Text] [Related]
8. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties. Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922 [TBL] [Abstract][Full Text] [Related]
9. New multipotent tetracyclic tacrines with neuroprotective activity. Marco-Contelles J; León R; de los Ríos C; García AG; López MG; Villarroya M Bioorg Med Chem; 2006 Dec; 14(24):8176-85. PubMed ID: 17005406 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase. Huang L; Luo Z; He F; Lu J; Li X Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease. Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents. Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Huang L; Shi A; He F; Li X Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease. Samadi A; de la Fuente Revenga M; Pérez C; Iriepa I; Moraleda I; Rodríguez-Franco MI; Marco-Contelles J Eur J Med Chem; 2013 Sep; 67():64-74. PubMed ID: 23838422 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents. Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459 [TBL] [Abstract][Full Text] [Related]
17. New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties. León R; de los Ríos C; Marco-Contelles J; Huertas O; Barril X; Luque FJ; López MG; García AG; Villarroya M Bioorg Med Chem; 2008 Aug; 16(16):7759-69. PubMed ID: 18640842 [TBL] [Abstract][Full Text] [Related]
18. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents. Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006 [TBL] [Abstract][Full Text] [Related]
19. Novel Pyridine-Containing Sultones: Structure-Activity Relationship and Biological Evaluation as Selective AChE Inhibitors for the Treatment of Alzheimer's disease. Zhang H; Wu C; Chen X; Zhang Z; Jiang X; Qin HL; Tang W ChemMedChem; 2021 Oct; 16(20):3189-3200. PubMed ID: 34036731 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines. Maalej E; Chabchoub F; Samadi A; de los Ríos C; Perona A; Morreale A; Marco-Contelles J Bioorg Med Chem Lett; 2011 Apr; 21(8):2384-8. PubMed ID: 21411323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]